drugset / Trial / NCT04903184
Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of this study is to explore potential for reduction of incidence and/or morbidity of SARS-CoV-2 infection in healthcare personnel. The study will include a comparison between placebo and RUTI® vaccine in a 2:1 design.
Timeline
- Start
- 2021-01-06
- Primary completion
- 2021-11-11
- Completion
- 2021-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RUTI® | Vaccine | 25 ug | Subcutaneous |